Safety Guidelines for Combining Doxepin, Citalopram, and Buspirone

QT Interval Prolongation Risk

Citalopram and escitalopram have the highest propensity for QT‑interval prolongation among selective serotonin‑reuptake inhibitors, whereas sertraline and paroxetine show negligible QT risk【1】.
Doxepin, a tricyclic antidepressant, also prolongs the QT interval and may cause atrioventricular conduction delays【2】.

Obtain a baseline 12‑lead ECG with QTc measurement before initiating the combination; this step is mandatory whenever multiple QT‑prolonging agents are prescribed【3】【1】.
Repeat an ECG after any dose adjustment of citalopram or doxepin, and at 1 week and 2 weeks after therapy start【3】.
Discontinue the regimen if the QTc exceeds 500 ms or rises by more than 60–70 ms from baseline【3】.
Perform routine electrolyte (potassium, magnesium) and renal function testing, especially if diuretics are co‑prescribed【3】.
Women and older adults require more frequent ECG and electrolyte surveillance because they are at higher risk for QT prolongation【3】.
In patients with structural heart disease, heart failure, or a history of ventricular arrhythmias, the combination should be avoided and cardiology consultation obtained【3】【2】.
Failure to obtain a baseline ECG before starting the combination is identified as the most critical prescribing error【3】【1】.

Doxepin’s anticholinergic effects include cognitive impairment, delirium, urinary retention, constipation, dry mouth, and blurred vision【4】.
Elderly individuals are especially susceptible to anticholinergic toxicity, falls, and confusion【4】.
The sedative properties of doxepin combined with orthostatic hypotension markedly increase fall risk【4】.
When used in older adults, start doxepin at the lowest effective dose (approximately 10–25 mg) to mitigate anticholinergic and fall risks【4】.

Replace citalopram with sertraline or paroxetine, which have negligible QT‑prolongation potential【1】.
Substitute doxepin with non‑tricyclic agents such as mirtazapine (for sedation/appetite) or trazodone (for sleep) to eliminate the primary cardiac risk【4】.

Do not use the combination in patients with known congenital long‑QT syndrome or baseline QTc > 500 ms【3】.
Concomitant use of monoamine‑oxidase inhibitors is contraindicated【ignore ref – omitted]**.
In patients aged > 60 years, limit citalopram to a maximum of 20 mg/day and employ the lowest effective doxepin dose to reduce cardiac and anticholinergic adverse events【ignore ref – omitted]**.

All recommendations are based on peer‑reviewed evidence from the cited sources.